Recent Articles from Business Wire

Procore Technologies, Inc. (NYSE: PCOR), the leading global provider of construction management software, today announced the launch of its connected Common Data Environment (CDE)—a purpose-built CDE from the ground up on a single platform to unify and verify project data from approved design to handover, capturing evidence in the flow of work to help keep the digital record aligned with site reality. This trusted data foundation allows agentic AI to act across the full construction lifecycle.

83% of U.S. bettors are keen to use cryptocurrency to fund wagers with online sportsbooks, when permitted, according to research issued today by leading payments platform Paysafe (NYSE: PSFE). The company’s All the Ways Players Pay: Crypto Edition report also suggests that when a state permits crypto payments, sportsbooks supporting deposits by digital assets and even payouts will gain a competitive edge in player acquisition and retention.

Omdia’s latest TV & Video market data shows global online video subscriptions reached 2.24 billion at the end of 2025, up 17.6% year on year from 1.9 billion in 2024. However, growth is expected to slow to single digits in 2026 as the market enters a more mature phase. Meanwhile, global pay-TV subscriptions continued their gradual decline, falling 1.8% year on year to 1.03 billion. The balance of the global TV and video market continues to shift toward streaming, with online video accounting for 68.4% of the combined 3.3 billion subscriptions worldwide.

Enterprise AI spending is climbing rapidly, with boards racing to deploy the technology faster than they can measure whether it works. According to the latest IDC InfoBrief, commissioned by Expereo*, around 70% of organizations are investing in AI, motivated by its potential or by the fear of falling behind the competition, but they lag in disciplined ROI evaluation, and one in five (20%) admit they are investing aggressively in AI with little evaluation, driven by the fear of being left behind.

Krisp, the leader in real-time Voice AI, today announced the appointment of Graham Brown as Chief Growth Officer, Europe and Africa. Brown will lead Krisp's commercial strategy across the UK, Europe and Africa, reporting to Chief Commercial Officer Harry Folloder.

Teledyne Gas and Flame Detection (Teledyne GFD), part of Teledyne Technologies Incorporated (NYSE:TDY), is responding to updated International Maritime Organization (IMO) recommendations for entering enclosed spaces aboard ships with gas detection solutions that help operators strengthen atmospheric monitoring and address evolving safety expectations.

ICL Group Ltd. (NYSE & TASE: ICL) (the “Company” or “ICL”) hereby announces that it has commenced an offering (the “Offering”) of new unsecured senior notes (the “Notes”), the amount and terms of which have yet to be determined. The Company intends to use the net proceeds from the Offering for general corporate purposes, including the repayment, in part or in full, of outstanding borrowings under its revolving credit facility which matures in April 2030 (the “Revolving Credit Facility”) (following such repayment, the Revolving Credit Facility will remain available to ICL in accordance with its terms), the repayment of other debt, capital expenditures, investments and acquisitions, supporting our strategy.

Ascensia Diabetes Care, a global diabetes care company and subsidiary of PHC Holdings Corporation (TSE 6523), today announced the launch of CONTOUR®COMFORT pen needles, further strengthening its CONTOUR® portfolio with a solution that improves the everyday injection experience.

New research from Ripjar, the AI-native provider of smarter screening solutions, reveals that financial services decision-makers rate adverse media screening as one of the most critical disciplines in their risk frameworks today. 93% of leaders rate is as critical, but only 77% actually conduct it, and 58% still rely on manual internet searches.

Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset (“RWA”) tokenization technologies, today announced the execution on May 30, 2026 of a non-binding term sheet relating to a potential $2.0 billion dilutive structured financing transaction, pursuant to which the Company may issue shares at a purchase price of $1.55 to $2.00 per common share to an institutional investment fund and a UK-based regulated structured institutional investment platform operating across technology, mining, and real assets (together, the “Counterparty”), in exchange for preferred units in an investment vehicle holding a portfolio of fixed income securities valued at approximately $2.0 billion (the “fixed income vehicle”). The proposed transaction is intended to provide Datavault AI with a structured pathway to access secured financing to support the Company’s digital asset exchanges by establishing a collateral base through the Company’s acquisition of preferred units in the fixed income vehicle.

Blue Language Labs today emerged from stealth to introduce the coordination layer for AI agents that do real business. Built on BLUE, the company’s open-sourced protocol for structuring agent-driven business processes, the platform helps businesses use agents to assemble revenue-generating offers, find partners, coordinate approvals, and run multi-party processes from agreement through settlement in a way every participant can verify.

Corient today announced the successful completion of its previously announced acquisitions of Stonehage Fleming and Stanhope Capital Group, marking a significant milestone in its continued global expansion.

DDN, the global leader in AI and data intelligence solutions, today announced new advancements to its AI data intelligence platform designed to help enterprises deploy agentic AI faster, strengthen governance and security, reduce operational complexity, and maximize GPU efficiency across enterprise-scale AI factories. The innovations deliver real-time observability, policy-based control, secure multi-tenant isolation, and AI-native data orchestration optimized for large-scale training, inference, and autonomous AI workloads, helping organizations move AI initiatives from pilot to production with improved performance and ROI.

Uber (NYSE: UBER), and Autobrains announced at GTC Taipei today a strategic collaboration to launch a robotaxi program in Munich, combining Uber’s ride-hailing platform, Autobrains’ agentic autonomous driving intelligence, and NVIDIA DRIVE robotaxi-ready level 4 Hyperion platform to support scalable autonomous mobility for commercial ride-hailing.

Synera, the agentic AI platform powering the full product development value chain, today announced it is one of the first companies in the design and simulation space to work with NVIDIA NemoClaw, blueprint for building specialized agents capable of executing long-running engineering workflows safely, securely, at enterprise scale.

At Computex 2026, Cadence (Nasdaq: CDNS) announced the industry’s first fully autonomous virtual agentic AI design engineer, extending the ChipStack™ AI Super Agent to Level-5 autonomy. Built on Cadence’s AI-driven electronic design automation (EDA) portfolio with NVIDIA Nemotron models, and secured by NVIDIA OpenShell runtime, the new agentic capabilities enable customers to run dynamic simulations in automated workflows. At NVIDIA, 1000s of engineers are using billions of compute hours per year to run millions of tests to verify their designs. Each engineer will use ChipStack agents to run hundreds of dynamic simulations with Cadence® Xcelium™ Logic Simulation and Jasper® Formal Verification, delivering over 40X faster RTL validation cycles and reducing a typical five-week verification loop to less than a day, dramatically accelerating the validation of complex semiconductor designs.

COMPUTEX – HPE (NYSE: HPE) today announced the expansion of its industry-leading server portfolio with the introduction of the HPE ProLiant Compute DL394 Gen12, powered by NVIDIA Vera CPU. This next-generation server is engineered specifically to address the compute demands of emerging high-performance AI and data processing workloads delivering industry-leading agentic AI CPU performance, memory bandwidth, and low latency. Built on a foundation of advanced architecture, the platform also features HPE’s enterprise-grade Integrated Lights-Out (iLO) as security, while HPE Compute Ops Management provides a unified dashboard to manage and automate server environments.

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that new data from its obesity portfolio will be presented at the 2026 Scientific Sessions of the American Diabetes Association® (ADA). The insights demonstrate significant progress in addressing a range of unmet needs for people living with obesity or overweight such as long-term treatment adherence, which could be supported by a favorable safety and tolerability profile.

Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) (the “Company” or “we”) hereby announces that Glass Lewis & Co., LLC (“Glass Lewis”), a leading proxy advisory firm, has issued a report recommending that shareholders vote “FOR” all proposals to be entered at the Company’s upcoming 53rd Regular General Meeting of Shareholders scheduled for June 18, 2026.

Morse Micro, the world’s leading Wi-Fi HaLow silicon provider, today announced the MM8108-M20, a high-power Wi-Fi HaLow module designed to help product teams in the US and Canada bring long-range, low-power Wi-Fi HaLow devices to market faster.

COMPUTEX – Power Integrations (NASDAQ: POWI), the leader in high-voltage integrated circuits for energy-efficient power conversion, today introduced two new ultra-slim, compact auxiliary power supply reference designs for 800 VDC AI data centers. The single-output, 15 W design is only 30 mm by 30 mm with a 7 mm profile, while the isolated, six-rail, 35 W design is only 80 mm by 60 mm with an 8 mm profile. Optimized specifically for the NVIDIA Kyber liquid-cooled, blade-rack architecture, these ultra-compact solutions free up approximately 30 percent space on densely packed main power distribution boards (PDBs) with an estimated 30 percent reduction in the BOM count—streamlining design and improving overall reliability. These designs are highly efficient with at least 88 percent efficiency across line and load.

Mobvista (1860.HK), a leading technology platform providing global growth solutions, today announced its financial results for the quarter ended March 31, 2026.

Ventiva®, a leader in solid-state cooling solutions, today announced at Computex 2026 a strategic partnership with ASUS to explore next-generation thermal architectures for compact AI computing systems. Through this collaboration, the companies will evaluate how Ventiva's ionic cooling technology can support future ASUS NUC and Mini-PC designs.

Japan’s life insurers have increasingly relied on reinsurance in recent years, with the overall cession rate as a percentage of total gross premium written for the segment rising to more than 24% in 2023 and 2024 from just under 10% in 2020, according to a new AM Best report.

Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global Embodied AI (EAI) ecosystem company, today shared a weekly business update from YT Jia, Founder and Global CEO of FF.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verra Mobility Corporation (“Verra” or “the Company”) (NASDAQ: VRRM) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Photronics, Inc. (“Photronics” or “the Company”) (NASDAQ: PLAB) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Caesars Entertainment, Inc. (“Caesars” or “the Company”) (NASDAQ: CZR) for potential breaches of fiduciary duty on the part of its directors and management.

Taylor Morrison Home Corporation (NYSE: TMHC) and Berkshire Hathaway Inc. (NYSE: BRK.A; BRK.B) jointly announced today that they have reached a definitive agreement for Berkshire Hathaway to acquire Taylor Morrison for $72.50 per common share in cash, representing a total equity value for Taylor Morrison of approximately $6.8 billion and total enterprise value of approximately $8.5 billion. The acquisition price represents a 24% premium to Taylor Morrison’s latest closing price of $58.50 on May 29, 2026.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Gap, Inc. (“Gap” or “the Company”) (NYSE: GAP) for violations of the securities laws.

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced positive overall survival (OS) results from the Phase III HARMONi-6 trial, conducted in China and sponsored by Summit’s partner Akeso, Inc. (HKEX Code: 9926.HK), will be presented today as part of the Plenary Session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of the next-generation of Lens, its pioneering agentic AI platform designed to accelerate drug development and research. This evolution seamlessly connects Tempus’ multimodal data, AI tooling and computational infrastructure to deliver actionable insights at the pace required for drug development.

Pfizer Inc. (NYSE: PFE) today announced detailed progression-free and overall survival results from Cohort 3, a randomized cohort of the Phase 3 BREAKWATER trial, evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and FOLFIRI (fluorouracil, leucovorin, and irinotecan) versus FOLFIRI with or without bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) with a BRAF V600E mutation. These results will be presented today in a late-breaking oral presentation (Abstract LBA3503) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in the Annals of Oncology.

Kelonia Therapeutics, Inc., a clinical-stage biotechnology company pioneering in vivo gene delivery, today shared positive updated results from inMMyCAR, the ongoing first-in-human Phase 1 study of KLN-1010 in patients with relapsed and refractory multiple myeloma (RRMM), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.

Primary results from the Phase II ARACOG (AFT-47) trial, a head-to-head randomized trial conducted by Alliance Foundation Trials LLC, showed that patients treated with NUBEQA® (darolutamide; n=55) experienced significantly less decline in objective cognitive performance over 24 weeks compared with those treated with enzalutamide (n=56).

Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing novel complex biologic therapeutics, today announced updated data from the Phase 1/2 study of JK06, a 5T4-targeted antibody drug conjugate (ADC), in patients with unresectable locally advanced or metastatic solid tumors, including non-small cell lung cancer (NSCLC) and breast cancer. The data are being presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29 – June 2, 2026, in Chicago, Illinois.

BW LPG Limited (“BW LPG”, the “Company”, OSE ticker code: “BWLPG.OL”), the world’s leading owner and operator of LPG vessels, announces that it has signed a contract for the construction of eight 90’cbm Panamax Very Large Gas Carriers (VLGCs), for a total consideration of about US$940 million, subject to the final technical specifications. The newbuildings are expected to be delivered sequentially from the start of 2029 until the second quarter of 2030.

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced new data from its rare liver disease programs. Late-breaking results from the Phase 2b VISTAS study of volixibat in PSC and Phase 2b AZURE-1 study of brelovitug in HDV, alongside data featuring its established therapy, LIVMARLI® (maralixibat), in PFIC, were presented at the European Association for the Study of the Liver (EASL) International Liver Congress 2026.

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Sportradar Group AG (NASDAQ: SRAD) Class A ordinary shares between November 7, 2024 and April 21, 2026, both dates inclusive (the “Class Period”), have until July 17, 2026 to seek appointment as lead plaintiff of the Sportradar class action lawsuit. Captioned Smale v. Sportradar Group AG, No. 26-cv-04112 (S.D.N.Y.), the Sportradar class action lawsuit charges Sportradar as well as certain of Sportradar’s top executive officers with violations of the Securities Exchange Act of 1934.

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Commvault Systems, Inc. (NASDAQ: CVLT) securities between April 29, 2025 and January 26, 2026, inclusive (the “Class Period”), have until July 17, 2026 to seek appointment as lead plaintiff of the Commvault class action lawsuit. Captioned Imbert v. Commvault Systems, Inc., No. 26-cv-05654 (D.N.J.), the Commvault class action lawsuit charges Commvault as well as certain of Commvault’s top current and former executive officers with violations of the Securities Exchange Act of 1934.

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal trial, which showed that CABOMETYX® (cabozantinib) provided significant improvements in progression-free survival (PFS) versus placebo in patients with previously treated advanced neuroendocrine tumors (NET) regardless of functional status. These data will be presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting to be held from May 29 – June 2 in Chicago.

Massive Bio today announced the next-generation product suite within Reticulum Nexus™, introducing a coordinated set of AI agents, intelligent calculators, signal engines, patient navigation tools, and physician referral workflows designed to move oncology access from fragmented trial matching to closed-loop orchestration.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of the PRECISION Challenge, a national initiative engineered to accelerate the next generation of oncology breakthroughs leveraging its foundational model. The PRECISION Challenge aims to unlock breakthroughs in oncology at scale by providing access to data, funding, and expertise to multidisciplinary teams around the world who seek to make bold advances in cancer treatment and improve patient outcomes.

Summit Therapeutics Inc. (NASDAQ: SMMT) today presented new results from the AK112-206 trial (NCT05382442), a global, open-label, multicenter Phase II study in first-line metastatic colorectal cancer (mCRC) co-sponsored by Summit and Akeso, featuring the novel, potential first-in-class investigational bispecific antibody ivonescimab. The data were presented today at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced results from the ENZAMET trial presented at the 2026 ASCO Annual Meeting. The analysis demonstrates that the Decipher Prostate test identifies which men with metastatic prostate cancer benefit from adding the chemotherapy docetaxel to standard hormonal therapy (ADT plus enzalutamide), known as triplet therapy, and who can safely avoid it, providing the first Level 1B 1 evidence for a genomic test guiding this decision. Complementary data presented at the meeting also reinforce Decipher Prostate's clinical utility in high-risk localized disease.

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the introduction of Tempus Preview, an application providing rapid, clinically significant insights that close the gap between the time of order and delivery of insights. Representing a significant paradigm shift in precision oncology workflows, Tempus Preview offers preliminary results in the critical window between when a diagnostic test is ordered and when final sequencing results are delivered by surfacing key mutation predictions within approximately 24 hours of tissue receipt.

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced detailed efficacy and safety results from RINGSIDE, the global, randomized, double-blind, placebo-controlled Phase 3 trial of varegacestat in patients with progressing desmoid tumors. The data are being presented today in an oral abstract session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Immunome submitted an NDA for varegacestat to the FDA in April 2026.

Pfizer Inc. (NYSE: PFE) today announced detailed results from the pivotal Phase 3 TALAPRO-3 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide), an androgen receptor pathway inhibitor (ARPI), in men with homologous recombination repair (HRR) gene-mutated metastatic castration-sensitive prostate cancer (mCSPC), also known as metastatic hormone-sensitive prostate cancer (mHSPC). These results will be presented today in a late-breaking oral presentation (Abstract LBA5007) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The New England Journal of Medicine.

Tune Therapeutics, a leading epigenome editing company, presented new data today at the European Association for the Study of Liver (EASL) Congress in Barcelona, Spain, demonstrating the first clinical evidence of epigenetic silencing in hepatitis B virus (HBV).

Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties (“FCPT” or the “Company”), is pleased to announce the signing of a definitive agreement to acquire up to 102 Mission Pet Health (“MPH”) veterinary properties for a purchase price of up to $268.0 million from Shore Capital Real Estate Partners Fund I.

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of AeroVironment, Inc. (NASDAQ: AVAV) securities between June 25, 2025 and March 10, 2026, both dates inclusive (the “Class Period”), have until July 27, 2026 to seek appointment as lead plaintiff of the AeroVironment class action lawsuit. Captioned Norrell v. AeroVironment, Inc., No. 26-cv-01429 (E.D. Va.), the AeroVironment class action lawsuit charges AeroVironment and certain of AeroVironment’s top current and former executive officers with violations of the Securities Exchange Act of 1934.

Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Lucid Group, Inc. (NASDAQ: LCID) securities between February 25, 2026 and April 13, 2026. Lucid is a technology company that designs, develops, manufactures, and sells electric vehicles (“EVs”), EV powertrains, and battery systems.

Ferrari Films founder, attorney, and producer Stacy Kemp Ferrari today issued a point-by-point rebuttal to a Forbes article asserting that Section 168(k) of the Internal Revenue Code is "worthless as a tax shelter to raise financing for films." Ferrari contends the article contains critical legal oversights that, if left unchallenged, could mislead investors and producers who may have entirely lawful and well-structured grounds to benefit from the statute.

The law firm of Kirby McInerney LLP continues its investigation on behalf of York Space Systems Inc. (“York Space Systems” or the “Company”) (NYSE:YSS) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices.

Tanner Health, a leading nonprofit healthcare system serving west Georgia and east Alabama, today announced its go-live with Hyro, the leading Responsible AI Assistant Platform for health care, to streamline patient access and improve call center efficiency.

KBRA assigns a long-term rating of AA+ with a Stable Outlook to the State of Illinois (the "State"), Build Illinois Bonds (Sales Tax Revenue Bonds), Junior Obligation Series A and B of June 2026 (the "Junior Bonds"). KBRA additionally affirms the long-term rating of AA+ with a Stable Outlook for the State's outstanding parity Junior Obligation Build Illinois Bonds.

Syncora Guarantee Inc. (“Syncora Guarantee”) today announced that certain financial information of Syncora Guarantee has been made available on Syncora Guarantee's website (www.syncoraguarantee.com). The information posted is Syncora Guarantee’s Statutory Basis Financial Statements Years Ended December 31, 2025 and 2024 With Report of Independent Auditors.

Institutional Property Advisors (IPA), a division of Marcus & Millichap (NYSE:MMI) dedicated to serving the company’s institutional clients, announced today that Peter Katz, IPA executive managing director investments, advised Harrison Street Asset Management (HSAM) in HSAM’s sale of a 12-property, 7,578-bed student housing portfolio to a joint venture between Scion Group (Scion) and an Ares Real Estate fund (Ares) for approximately $910 million. Katz was engaged to consult on portfolio strategy and asset composition.

Sable Offshore Corp. (“Sable”)(NYSE: SOC) plans to post a new investor presentation to its corporate website before market open on Monday, June 1, 2026 and plans to host a conference call to discuss the new investor presentation on Monday June 1, 2026 at 10:00am CDT / 11:00am EDT.

Saba Capital Income & Opportunities Fund II (NYSE: SABA) (the “Fund”), a registered closed-end management investment company listed on the New York Stock Exchange, is notifying shareholders, prospective shareholders, and third parties of the sources of distributions pursuant to Section 19(a) of the Investment Company Act of 1940 (the “Investment Company Act”).

Saba Capital Income & Opportunities Fund (NYSE: BRW) (the “Fund”), a registered closed-end management investment company listed on the New York Stock Exchange, is notifying shareholders, prospective shareholders, and third parties of the sources of distributions pursuant to Section 19(a) of the Investment Company Act of 1940 (the “Investment Company Act”).

Kraken, one of the world’s longest-standing, most liquid and secure cryptocurrency platforms, has set out plans to launch the first CFTC-regulated perpetual futures in the US in the next 30 days.

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today presented new overall survival data from its pivotal Phase 3 ROSELLA trial of Lifyorli™ (relacorilant) plus nab-paclitaxel (a taxane chemotherapy) in an oral presentation at the ASCO 2026 (American Society of Clinical Oncology) Annual Meeting.

Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), BlackRock Enhanced Large Cap Core Fund, Inc. (NYSE: CII), BlackRock Science and Technology Trust (NYSE: BST), BlackRock Science and Technology Term Trust (NYSE: BSTZ), BlackRock Technology and Private Equity Term Trust (NYSE: BTX), BlackRock Capital Allocation Term Trust (NYSE: BCAT), and BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT) (collectively, the “Funds”) paid the following distributions per share:

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals.

The Principal Real Estate Income Fund (NYSE:PGZ) announces the sources of a distribution paid on May 29, 2026 of $0.1050 per share to shareholders of record at the close of business on May 14, 2026, pursuant to the Fund's managed distribution plan. This press release is issued as required by an exemptive order granted to the Fund by the U.S. Securities and Exchange Commission and includes the notice below sent to shareholders regarding the source of the distribution.

State Street Corporation (NYSE: STT) announced today that its Chief Financial Officer, John Woods, will present at the Morgan Stanley U.S. Financials Conference in New York, NY on Wednesday, June 10, 2026 at approximately 1:45 pm ET.

QXO, Inc. (“QXO”) (NYSE: QXO) today announced that, in connection with its pending acquisition of TopBuild Corp. (“TopBuild”), it has commenced, through its wholly-owned subsidiary Titanium MergerCo, Inc., a Delaware corporation (the “Company”), tender offers (collectively, the “Tender Offers”) to purchase for cash any and all of the outstanding (i) 4.125% Senior Notes due 2032 (the “2032 Notes”) and (ii) 5.625% Senior Notes due 2034 (the “2034 Notes” and, together with the 2032 Notes, the “Notes”) of TopBuild.

PGIM High Yield Bond Fund, Inc. (NYSE: ISD), PGIM Global High Yield Fund, Inc. (NYSE: GHY) and PGIM Short Duration High Yield Opportunities Fund (NYSE: SDHY) declared today monthly distributions for June, July and August 2026. The distribution amounts and schedule for each fund appears below:

MFS Investment Management® (MFS®) announced today monthly distributions of the following closed-end funds, all with declaration dates of May 29, 2026, ex-dividend dates of June 8, 2026, record dates of June 8, 2026, and payable dates of June 15, 2026:

PACIFIC COAST OIL TRUST (OTC–ROYTL) (the “Trust”), a royalty trust formed by Pacific Coast Energy Company LP (“PCEC”), announced today that there will be no cash distribution to the holders of its units of beneficial interest of record on May 27, 2026 based on the Trust’s calculation of net profits generated during March 2026 (the “Current Month”) as provided in the conveyance of net profits interests and overriding royalty interest (the “Conveyance”). As further described below under “Update on Estimated Asset Retirement Obligations,” based on information from PCEC, any monthly payments that PCEC may make to the Trust may not be sufficient to cover the Trust’s administrative expenses and outstanding debt to PCEC, and therefore the likelihood of distributions to the unitholders in the foreseeable future is extremely remote. As further described below under “Status of the Dissolution of the Trust”, because the annual cash proceeds received by the Trust from its net profits interests (the “Net Profits Interests”) and 7.5% overriding royalty interest (the “Royalty Interest”) totaled less than $2.0 million for each of 2020 and 2021, the amended and restated trust agreement governing the Trust (the “Trust Agreement”) provides that the Trust is to be dissolved and wound-up. All financial and operational information in this press release has been provided to the Trustee by PCEC.

Essex Property Trust, Inc. (NYSE:ESS) announced today that Angela L. Kleiman, President and CEO, will be participating in a roundtable presentation at the 2026 Nareit REITweek Conference on Wednesday, June 3, 2026 at 2:00 p.m. Eastern Time.

indie Semiconductor (Nasdaq: INDI), an automotive solutions innovator, today announced that it has granted equity awards (the “Inducement Grants”) under its 2023 Inducement Incentive Plan to new employees who joined indie. The grants were previously approved by the Compensation Committee of the Board of Directors of indie Semiconductor. Information regarding the equity awards can be found on the company's investor relations website at: https://investors.indie.inc/news/default.aspx

KKR & Co. Inc. (NYSE: KKR) announced today that Raj Agrawal, Partner and Global Head of Real Assets, will present at the Morgan Stanley US Financials Conference on Wednesday, June 10, 2026 at 8:15 AM ET.